Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Analysis

Editor-in-Chief

ISSN (Print): 1573-4129
ISSN (Online): 1875-676X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Development and Validation of a Sensitive LC-MS/MS Method for Determination of Betamethasone in Human Plasma. Application to a Pharmacokinetic Study of Healthy Mexican Subjects

Author(s): Omar Patiño-Rodríguez, Abraham Escobedo-Moratilla, Rosa María Martínez-Medina, Irma Torres-Roque, Maricela Martínez-Delgado and José Pérez-Urizar *

Volume 15, Issue 1, 2019

Page: [2 - 8] Pages: 7

DOI: 10.2174/1573412913666170912111945

Price: $65

Abstract

Background: Synthetic glucocorticoids like Betamethasone (BE) are used in the treatment of inflammatory diseases due to its effective and potent effect. BE is available in three different esters: dipropionate (BD), sodium phosphate (BP), and acetate (BA). BD/BP combined in suspension has antiinflammatory, anti-allergic, and anti-rheumatic effects. The aim of this study was to describe the bioavailability of a single-dose of the injectable formulation of BP/BD in healthy Mexican subjects.

Methods: This was a randomized, open-label, longitudinal, not therapeutic, single-dose trial of an intramuscular administration of BD/BP (5 mg/2 mg), in healthy Mexican subjects under fasting condition. Twenty-six healthy Mexicans volunteers of both genders who were between the ages of 18 and 45 were enrolled in the study.

Results: From non-compartmental estimation of data, it was observed that the BE highest mean concentration was 15.70 ± 3.93 ng/mL reaching it in 2.83 ± 1.35 h. The values of elimination half-life were 10.89 ± 2.02 h. No clinically significant adverse effects were presented during the study.

Conclusion: The reported PK parameters for BE suggest that the BD/BP suspension has a similar release velocity in Mexican healthy subjects compared with previous studies.

Keywords: LC-MS/MS, betamethasone, dipropionate, sodium phosphate, pharmacokinetics, glucocorticoid, human plasma.

« Previous Next »
Graphical Abstract

[1]
Van Der Velden, V.H. Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma. Mediators Inflamm., 1998, 7, 229-237.
[2]
Simon, A.; de Almeida Borges, V.R.; Cabral, L.M.; de Sousa, V.P. Development and validation of a discriminative dissolution test for betamethasone sodium phosphate and betamethasone dipropionate intramuscular injectable suspension. AAPS PharmSciTech, 2013, 14, 425-434.
[3]
Diprospan Insert, consulted in July 2016.http://www. old.health.gov.il/units/pharmacy/trufot/alonim/4136.pdf
[4]
PubChem. Betamethasone, consulted in Abril. 2017.https://pubchem.ncbi.nlm.nih.gov/compound/betamethasone#section=Top
[5]
Salem, I.I.; Najib, N.M. Pharmacokinetics of betamethasone after single-dose intramuscular administration of betamethasone phosphate and betamethasone acetate to healthy subjects. Clin. Ther., 2012, 34, 214-220.
[6]
He, C.; Fan, H.; Tan, J.; Zou, J.; Zhu, Y.; Yang, K.; Hu, Q. Pharmacokinetics of betamethasone and betamethasone 17-monopropionate in Chinese healthy volunteers after intramuscular injection of betamethasone phosphate/betamethasone dipropionate. Arzneimittelforschung, 2011, 61, 417-420.
[7]
Jusko, W.J.; Pyszczynski, N.A.; Bushway, M.S.; D’Ambrosio, R.; Mis, S.M. Fifteen years of operation of a high-performance liquid chromatographic assay for prednisolone, cortisol and prednisone in plasma. J. Chromatogr. B., 1994, 658, 47-54.
[8]
Lai, C.C.; Tsai, C.H.; Tsai, F.J.; Wu, J.Y.; Lin, W.D.; Lee, C.C. Rapid screening assay of congenital adrenal hyperplasia by measuring 17 alpha-hydroxyprogesterone with high-performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots. J. Clin. Lab. Anal. Title., 2002, 16, 20-25.
[9]
Patiño-Rodríguez, O.; Zapata-Morales, J.R.; Escobedo-Moratilla, A.; Diaz de Leon-Cabrero, M.; Torres-Roque, I.; Perez-Urizar, J. Determination of pinaverium bromide in human plasma by a sensitive and robust UPLC-MS-MS method and application to a pharmacokinetic study in Mexican subjects. J. Chromatogr. Sci., 2015, 53, 1373-1378.
[10]
Petersen, M.C.; Nation, R.L.; Mcbride, W.G.; Ashley, J.J.; Moore, R.G. Pharmacokinetics of betamethasone in healthy-adults after intravenous administration. Eur. J. Clin. Pharmacol., 1983, 25, 643-650.
[11]
Petersen, M.C.; Ashley, J.J.; Mcbride, W.G.; Nation, R.L. Disposition of betamethasone in parturient women after intramuscular administration. Br. J. Clin. Pharmacol., 1984, 18, 383-392.
[12]
Kabasaka, P.; Britt, E.; Yudis, M.D. Solubility of some steroids in water. J. Pharm. Sci., 1966, 55, 642.
[13]
Hirano, K.; Ichihashi, T.; Yamada, H. Studies on the absorption of practically water-insoluble drugs following injection. II. Intramuscular absorption from aqueous suspensions in rats. Chem. Pharm. Bull., 1981, 29, 817-827.
[14]
Iannitti, T.; Rottigni, V.; Palmieri, B. Corticosteroid transdermal delivery to targets welling, edema and inflammation following facial rejuvenation procedures. Drug Des. Dev. Ther., 2013, 7, 1035-1041.
[15]
Maccari, F. Improvement of inflammatory dermatoses severity and quality of life in patients treated with a betamethasone valerate plaster. J. Dermatolog. Treat., 2016, 27, 59-63.
[16]
Frizziero, A.; Causero, A.; Bernasconi, S.; Papalia, R.; Longo, M.; Sessa, V.; Sadile, V.; Greco, P.; Tarantino, U.; Masiero, S.; Rovati, S.; Frangione, V. Efficacy of betamethasone valerate medicated plaster on painful chronic elbow tendinopathy: a double-blind, randomized, placebo-controlled trial. Muscles Ligaments Tendons J., 2016, 6, 131-139.

Rights & Permissions Print Cite
Article Metrics
37
3
© 2024 Bentham Science Publishers | Privacy Policy